CD274 and neoplasm: Thus, PD-1 receptor blockade concurrently with the ChAdOx1-MVA 5T4 vaccine is the combination mediating the highest tumour protective effect, although some benefit of anti PD-L1 and LAG-3 therapy cannot be ruled out in this setting.